Potential neutralizing antibodies discovered for novel corona virus using machine learning

The fast and untraceable virus mutations take lives of thousands of people before the immune system can produce the inhibitory antibody. Recent outbreak of novel coronavirus infected and killed thousands of people in the world. Rapid methods in finding peptides or antibody sequences that can inhibit the viral epitopes of COVID-19 will save the life of thousands. In this paper, we devised a machine learning (ML) model to predict the possible inhibitory synthetic antibodies for Corona virus. We collected 1933 virus-antibody sequences and their clinical patient neutralization response and trained an ML model to predict the antibody response. Using graph featurization with variety of ML methods, we screened thousands of hypothetical antibody sequences and found 8 stable antibodies that potentially inhibit COVID-19. We combined bioinformatics, structural biology, and Molecular Dynamics (MD) simulations to verify the stability of the candidate antibodies that can inhibit the Corona virus.

[1]  John Steel,et al.  Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.

[2]  Xiaogen Zhou,et al.  Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1 , 2020, bioRxiv.

[3]  Peter M Tessier,et al.  Advances in Antibody Design. , 2015, Annual review of biomedical engineering.

[4]  D. Burton,et al.  A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies , 2009, Journal of Virology.

[5]  Hugues Bedouelle,et al.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.

[6]  K. Taylor,et al.  Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5 , 2017, Journal of Virology.

[7]  F. Plummer,et al.  Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain , 2009, Journal of Molecular Biology.

[8]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[9]  Damien Fleury,et al.  Antigen distortion allows influenza virus to escape neutralization , 1998, Nature Structural Biology.

[10]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[11]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[12]  Alexey Bochkarev,et al.  An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. , 2005, Journal of molecular biology.

[13]  Carol Carter,et al.  Crystal structure of dimeric HIV-1 capsid protein , 1996, Nature Structural Biology.

[14]  Joseph Gomes,et al.  MoleculeNet: a benchmark for molecular machine learning† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc02664a , 2017, Chemical science.

[15]  Lun Song,et al.  Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV , 2020, Cellular & Molecular Immunology.

[16]  Michael S. Diamond,et al.  Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope , 2012, PLoS pathogens.

[17]  J. Skehel,et al.  An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.

[18]  Yang Feng,et al.  Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody* , 2006, Journal of Biological Chemistry.

[19]  C. Hew,et al.  Structural basis for the neutralization and genotype specificity of hepatitis E virus , 2011, Proceedings of the National Academy of Sciences.

[20]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[21]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[22]  Peter D. Kwong,et al.  Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope , 2004, Journal of Virology.

[23]  Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking , 2020 .

[24]  Yaakov Levy,et al.  Simulations of proteins with inhomogeneous degrees of freedom: The effect of thermostats , 2008, J. Comput. Chem..

[25]  Gerhard Hummer,et al.  Native contacts determine protein folding mechanisms in atomistic simulations , 2013, Proceedings of the National Academy of Sciences.

[26]  R L Stanfield,et al.  Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Baker,et al.  Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold , 2011, Science.

[28]  W. Schief,et al.  Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. , 2011, Journal of molecular biology.

[29]  Andreas Radbruch,et al.  Antibodies and B cell memory in viral immunity. , 2007, Immunity.

[30]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[31]  Yoshihiro Kawaoka,et al.  A Shared Structural Solution for Neutralizing Ebolaviruses , 2011, Nature Structural &Molecular Biology.

[32]  P. Tavan,et al.  The "Hot-Solvent/Cold-Solute" Problem Revisited. , 2008, Journal of chemical theory and computation.

[33]  Tongqing Zhou,et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.

[34]  A. Walls,et al.  Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.

[35]  E. Stura,et al.  Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D6 1 , 2003, The Journal of Immunology.

[36]  Andreas P. Eichenberger,et al.  Definition and testing of the GROMOS force-field versions 54A7 and 54B7 , 2011, European Biophysics Journal.

[37]  E. Pai,et al.  Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications , 2009, Journal of Virology.

[38]  D. Burton,et al.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.

[39]  Hyejin Yoon,et al.  CATNAP: a tool to compile, analyze and tally neutralizing antibody panels , 2015, Nucleic Acids Res..

[40]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[41]  E. Hewitt The MHC class I antigen presentation pathway: strategies for viral immune evasion , 2003, Immunology.

[42]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[43]  G. Nybakken,et al.  Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.

[44]  R. Siva,et al.  Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus , 2016, Infectious Diseases of Poverty.

[45]  Emma J. Chory,et al.  A Deep Learning Approach to Antibiotic Discovery , 2020, Cell.

[46]  Peter D. Kwong,et al.  Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.

[47]  X. Qiu,et al.  Structures of protective antibodies reveal sites of vulnerability on Ebola virus , 2014, Proceedings of the National Academy of Sciences.

[48]  S. Ryu,et al.  Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism , 2007, Proceedings of the National Academy of Sciences.

[49]  Baoshan Zhang,et al.  Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 , 2013, Nature Structural &Molecular Biology.

[50]  S. Zolla-Pazner,et al.  Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies , 2010, Nature Structural &Molecular Biology.

[51]  M. Luftig,et al.  Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody , 2006, Nature Structural &Molecular Biology.

[52]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[53]  A. Gittis,et al.  Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein. , 2007, Virology.

[54]  Tianqi Chen,et al.  XGBoost: A Scalable Tree Boosting System , 2016, KDD.

[55]  Yang Liu,et al.  Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.

[56]  I. Wilson,et al.  Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. , 2016, Immunity.

[57]  T. Oliphant,et al.  Structural basis of West Nile virus neutralization by a therapeutic antibody , 2005, Nature.

[58]  Yuntao Wu,et al.  Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.

[59]  N. Bastien,et al.  Analysis of multimerization of the SARS coronavirus nucleocapsid protein , 2004, Biochemical and Biophysical Research Communications.

[60]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Yan Liu,et al.  A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.

[62]  J. Skehel,et al.  Structural evidence for recognition of a single epitope by two distinct antibodies , 2000, Proteins.

[63]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[64]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[65]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[66]  Martin H. Koldijk,et al.  A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses , 2011, Science.

[67]  Craig R. Miller,et al.  Initiating a watch list for Ebola virus antibody escape mutations , 2016, PeerJ.

[68]  E. Pai,et al.  Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus , 2008, The EMBO journal.

[69]  V. Tugarinov,et al.  NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding. , 2000, Structure.

[70]  Tongqing Zhou,et al.  Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.

[71]  P. Pandolfi,et al.  Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses , 2020, Cell Research.

[72]  J. Berg,et al.  Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.

[73]  Damien Fleury,et al.  A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site , 1999, Nature Structural Biology.

[74]  Thomas J Lane,et al.  MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.

[75]  A. Sharff,et al.  Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody , 2010, Proceedings of the National Academy of Sciences.

[76]  B. Haynes,et al.  Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design , 2016, Journal of Virology.

[77]  Structural basis for the antibody neutralization of Herpes simplex virus , 2013, Acta crystallographica. Section D, Biological crystallography.

[78]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[79]  John P. Moore,et al.  Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.

[80]  Richard J Kuhn,et al.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.

[81]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[82]  Amir Barati Farimani,et al.  Combining Physics-Based and Evolution-Based Methods to Design Antibodies Against an Evolving Virus , 2020 .

[83]  P. Kwong,et al.  Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F , 2010, Journal of Virology.

[84]  Peter A. Flach,et al.  Advances in Neural Information Processing Systems 28 , 2015 .

[85]  Dafna M. Abelson,et al.  Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain. , 2008, Journal of molecular biology.

[86]  Ron Diskin,et al.  Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design , 2011, Science.

[87]  S. Zolla-Pazner,et al.  Crystal Structures of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralizing Antibody 2219 in Complex with Three Different V3 Peptides Reveal a New Binding Mode for HIV-1 Cross-Reactivity , 2006, Journal of Virology.

[88]  Khaoula Ben Abdellafou,et al.  Enhanced SVM-KPCA Method for Brain MR Image Classification , 2020, Comput. J..

[89]  William C. Hwang,et al.  Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R* , 2006, Journal of Biological Chemistry.

[90]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[91]  L. Enjuanes,et al.  Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies , 2012, PLoS pathogens.

[92]  Alán Aspuru-Guzik,et al.  Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.

[93]  Elena Zaitseva,et al.  Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus , 2012, The EMBO journal.

[94]  Shaoqiang Li,et al.  Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.

[95]  Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, Emerging microbes & infections.

[96]  E. Domingo,et al.  A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules. , 2000, The Journal of general virology.

[97]  D. Kirchhofer,et al.  Structural insight into distinct mechanisms of protease inhibition by antibodies , 2007, Proceedings of the National Academy of Sciences.

[98]  Mario Roederer,et al.  Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.

[99]  D. Burton,et al.  Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 , 2012, Proceedings of the National Academy of Sciences.

[100]  C. Midgley,et al.  Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.

[101]  W G Laver,et al.  The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. , 1994, Structure.